STN#: BL 125591
Proper Name: Antihemophilic Factor (Recombinant), Single Chain
Tradename: AFSTYLA
Manufacturer: CSL Behring GmbH
Indication: For adults and children with hemophilia A (congenital Factor VIII deficiency) for:

On-demand treatment and control of bleeding episodes,
Routine prophylaxis to reduce the frequency of bleeding episodes,
Perioperative management of bleeding.

Product Information

Content current as of:

06/13/2023

Source

Medically Reviewed By: Felicia Eddings, Pharm.D.

Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting

"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.

Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.

View all posts by this author